Valuation: Valbiotis

Market Cap 18.69M 21.26M 17.4M 15.98M 30M 2.04B 30.4M 207M 80.77M 1.01B 79.81M 78.09M 3.48B P/E 2026 *
-2.53x
P/E 2027 * -9.88x
Enterprise Value 19.89M 22.62M 18.51M 17M 31.93M 2.17B 32.35M 220M 85.95M 1.07B 84.93M 83.1M 3.7B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 1.25x
Free-Float
97.31%
Yield 2026 *
-
Yield 2027 * -
1 day-1.27%
1 week+0.78%
Current month-2.99%
1 month-2.50%
3 months-19.75%
6 months-5.11%
Current year+12.39%
1 week 0.76
Extreme 0.76
0.83
1 month 0.74
Extreme 0.738
0.87
Current year 0.65
Extreme 0.653
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/03/2024
Chief Tech/Sci/R&D Officer - 01/09/2017
Director TitleAgeSince
Chairman 55 01/03/2017
Director/Board Member - 26/10/2017
Director/Board Member - 18/03/2019
Date Insider Type Main position Quantity % Market Cap.
28/1/22 Fiscal year

Founder

2,095 0.0215%
28/1/22 Others

Founder

42,480 0.4364%
10/7/21 Fiscal year

Chief Technology Officer

10,000 0.1030%
Change 5-day change 1-year change 3-year change Capi.($)
-1.27%+0.78%-14.00%-81.86% 21.28M
-1.82%+4.80%+54.32%+68.36% 57.28B
-0.27%+5.74%+40.26%+80.17% 54.99B
-1.52%-1.51%+3.59%+416.69% 23.18B
+2.80%-0.35%-18.57%-12.53% 22.59B
-1.13%+4.54%+22.73%-8.06% 20.46B
+1.57%+3.30%+27.41%-29.07% 17.56B
-0.10%+5.57%+38.63%+565.16% 15.67B
+5.29%0.00%+185.09%+332.66% 14.46B
+1.16%+1.09%+26.46%+186.40% 13.92B
Average +0.46%+1.35%+36.59%+151.79% 24.01B
Weighted average by Cap. +0.01%+1.93%+39.92%+138.60%

Financials

2026 *2027 *
Net sales 3.85M 4.38M 3.58M 3.29M 6.18M 420M 6.26M 42.6M 16.64M 207M 16.44M 16.09M 717M 13.25M 15.07M 12.33M 11.33M 21.27M 1.45B 21.55M 147M 57.26M 714M 56.58M 55.36M 2.47B
Net income -8.75M -9.95M -8.15M -7.48M -14.05M -955M -14.23M -96.82M -37.81M -471M -37.36M -36.56M -1.63B -5.35M -6.09M -4.98M -4.57M -8.59M -584M -8.7M -59.2M -23.12M -288M -22.85M -22.35M -996M
Net Debt 1.2M 1.37M 1.12M 1.03M 1.93M 131M 1.95M 13.28M 5.19M 64.64M 5.12M 5.01M 223M -2.1M -2.39M -1.95M -1.8M -3.37M -229M -3.42M -23.24M -9.08M -113M -8.97M -8.77M -391M
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
27/07/26 0.7800 -1.27% 46,371
24/07/26 €0.7900 +0.64% 45,239
23/07/26 €0.7850 -1.13% 105,596
22/07/26 €0.7940 +3.52% 35,224
21/07/26 €0.7670 -0.90% 82,138
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7900EUR
Average target price
2.228EUR
Spread / Average Target
+181.98%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALVAL Stock